Physician profile
David Mir
NPI 1295815439
$411.43
in general payments reported to CMS, 2019-2025
11 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $22.45 · 2024: $97.57 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $411.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $72.61 | 2025 | Omnipod |
| Exact Sciences Corporation | $65.15 | 2024-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $58.51 | 2025 | Bexsero, Pediarix, Rotarix |
| Novo Nordisk INC | $40.26 | 2024-2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $37.99 | 2025 | Invega Trinza, Invega Sustenna |
| Gilead Sciences, INC. | $29.26 | 2024 | |
| Redhill Biopharma INC. | $26.04 | 2025 | Talicia |
| Takeda Pharmaceuticals U.S.A., INC. | $25.72 | 2024 | Entyvio |
| Lilly USA, LLC | $22.45 | 2023 | Trulicity, Mounjaro |
| Sanofi Pasteur INC. | $16.82 | 2025 | |
| Pfizer INC. | $16.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.